Filter posts

Celgene CEO on New Multiple Myeloma Drug Approvals

Following on the heels of two big announcements in February, Celgene CEO Robert Hugin (one …

STEM Education Aimed at Girls

We write a fair bit about STEM education here at BIOtechNOW, so I was a …

Biotech Hall of Fame: Interview with Biotech’s First Investment Banker

Earlier this week, I had the opportunity to discuss biotech’s storied history with Fred Frank, …

Brazil Patent Policy: At a Crossroads

The Government of Brazil approaches the patent policy crossroads with two ministries wanting to move …

A Call to Arms for Renewable Fuels

BIO President & CEO Jim Greenwood delivered remarks on the Renewable Fuel Standard and participated …

Governor Quinn Invites Biotech Professionals to Chicago

Governor Pat Quinn has long been a champion of the bioscience industry – both for …

Celebrating George Washington Carver’s Contributions to Industrial Biotech

Every February we celebrate Black History Month recognizing the contributions and accomplishments of African Americans …

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

I was recently asked what the single biggest threat to the biotechnology industry is today.  …

Biobuck M&A in Full Gear

The 2012 M&A results are in and trends are mixed. Last year was a down …

BIO IP Counsels Committee Conference: Spring 2013 Line-Up

San Diego, California is the next site for the BIO IP Counsels Committee Conference.  On …